Issue 18, 2023

Correction: The Mössbauer effect using 57Fe-ferrabisdicarbollide ([o-57FESAN]): a glance into the potential of a low-dose approach for glioblastoma radiotherapy

Abstract

Correction for ‘The Mössbauer effect using 57Fe-ferrabisdicarbollide ([o-57FESAN]): a glance into the potential of a low-dose approach for glioblastoma radiotherapy’ by Ana B. Buades et al., Inorg. Chem. Front., 2022, 9, 1490–1503, https://doi.org/10.1039/D1QI01513C.

Associated articles

Article information

Article type
Correction
Submitted
09 Aug 2023
Accepted
09 Aug 2023
First published
21 Aug 2023
This article is Open Access
Creative Commons BY license

Inorg. Chem. Front., 2023,10, 5496-5496

Correction: The Mössbauer effect using 57Fe-ferrabisdicarbollide ([o-57FESAN]): a glance into the potential of a low-dose approach for glioblastoma radiotherapy

A. B. Buades, L. C. J. Pereira, B. J. C. Vieira, A. C. Cerdeira, J. C. Waerenborgh, T. Pinheiro, A. P. A. Matos, C. G. Pinto, J. F. Guerreiro, F. Mendes, F. Teixidor, C. Viñas and F. Marques, Inorg. Chem. Front., 2023, 10, 5496 DOI: 10.1039/D3QI90073H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements